Skip to ContentSkip to Navigation
Over onsNieuws en agendaNieuwsberichten

ERC Advanced Grant voor Cisca Wijmenga

22 november 2012
prof.dr. Cisca Wijmenga

De European Research Council (ERC) heeft een zogeheten Advanced Grant toegekend aan Cisca Wijmenga, hoogleraar Genetica en hoofd van de afdeling Genetica. Zij krijgt deze Advanced Grant voor haar onderzoek op het gebied van de ziekte coeliakie. Deze ziekte treft ongeveer 1% van de wereldbevolking. De ziekte wordt veroorzaakt door gluten, een normale voedingsstof maar van de oorsprong is nog maar weinig bekend. Meer kennis van de biomedische achtergronden kan de diagnose, preventie en behandeling van coeliakie verbeteren.

Cisca Wijmenga gaat de ziektemechanismen van coeliakie verder onderzoeken; hierbij wil zij gebruikmaken van genen met ziekteaanleg en gen-variaties om factoren die de ziekte initiëren nader te identificeren. Eerdere studies, die al 39 risicogenen voor coeliakie hebben geïdentificeerd, suggereren dat het mechanisme onder de ziekte wordt bepaald door ontregeling van de gen-expressie.

Meer informatie: UMCG nieuws, haar onderzoek, persoonlijke webpage

ERC Proposal -- Celiac disease: from lincRNAs to disease mechanism (CD-LINK)

Genome-wide association studies (GWAS) have provided important new insights into mechanisms underlying complex diseases. To date, over 2,000 genetic loci have been associated by single nucleotide polymorphisms (SNPs) to more than 250 common diseases, including celiac disease. Yet, most disease-SNPs are not located within protein-coding genes, providing a challenge in interpreting GWAS findings. This project examines how SNPs associated to celiac disease, with a focus on those outside the coding part of the genome, contribute to disease etiology. The results will provide the basis for new strategies for early detection and prevention of celiac disease and its complications.

Aim

This project investigates the disease mechanisms underlying celiac disease by using predisposing genes and disease-associated genetic variations as disease initiating factors. Specifically, we will investigate if lincRNAs are causally involved in celiac disease pathogenesis by regulating protein-coding genes and pathways associated with celiac disease. Since it is clear that celiac disease is driven by T cells, I will focus on those genes and lincRNAs from the 39 loci that are expressed in T cells.

Impact

Uncovering the specific mechanism by which genetic variation results in a disease phenotype will foster new biological insights and pinpoint the biological pathways involved in celiac disease. These discoveries may have direct clinical application as they may uncover potential therapeutic targets. We will provide a solid scientific basis for new diagnostic markers, particularly biomarkers, based on genetics and genomics.

Summary

Celiac disease affects at least 1% of the world population. Its onset is triggered by gluten, a common dietary protein, however, its etiology is poorly understood. More than 80% of patients are not properly diagnosed and they therefore do not follow a gluten-free diet, thereby increasing their risk for disease-associated complications and early death. A better understanding of the disease biology would improve the diagnosis, prevention, and treatment of celiac disease. This project investigates the disease mechanisms in celiac disease by using predisposing genes and genetic variants as disease initiating factors. Specifically, it will investigate if long, intergenic noncoding RNAs (lincRNAs) are causally involved in celiac disease pathogenesis by regulating protein-coding genes and pathways associated with the disease.

This project is based on two important observations by my group: (1) Our genetic studies, which led to identifying 39 celiac disease risk loci, suggest that the mechanism underlying the disease is largely governed by dysregulation of gene expression. (2) We uncovered a previously unrecognized role for lincRNAs that provides clues as to exactly how genetic variation causes disease, as this class of biologically important RNA molecules regulate gene expression. The research will be performed in CD4+ T cells, a severely affected cell type in disease pathology. I will first use celiac disease-associated protein-coding genes to delineate their regulatory pathways and then study the transcriptional programs of lincRNAs present in celiac disease loci. Next I will combine the information and investigate if the expressed lincRNAs modulate the pathways and affect T cell function, thereby discovering if lincRNAs are a missing link between non-coding genetic variation and protein-coding genes. Our findings may well lead to potential therapeutic targets and provide a solid scientific basis for new diagnostic markers, particularly biomarkers, based on genetics

Laatst gewijzigd:04 juli 2014 21:35
printOok beschikbaar in het: English

Meer nieuws

  • 09 februari 2018

    Virtual Reality therapie helpt mensen met psychose van angst en paranoia af

    Mensen met psychose die gepaard gaat met extreme achterdocht kunnen hun paranoia en angst overwinnen door te oefenen in Virtual Reality-omgevingen. Dit blijkt uit een gezamenlijk onderzoek van de Vrije Universiteit, Universitair Medisch Centrum Groningen...

  • 12 januari 2018

    Gratis online cursus over psychische problemen

    Het Universitair Medisch Centrum Groningen heeft een gratis online cursus over psychische gezondheid ontwikkeld, speciaal gericht op jongeren van 14 jaar en ouder, hun ouders en andere geïnteresseerden. In de deze MOOC (Massive Open Online Course) leren...

  • 10 januari 2018

    UMCG in 2018: investeren in verpleging, werkplezier en preventie

    Investeren in de verpleegkundige beroepsgroep, vergroten van werkplezier, ontbureaucratisering en preventie. Dat zijn de belangrijkste thema’s waar het UMCG aan werkt in 2018. Meer respect en ‘oog en oor’ houden voor elkaar (‘zie de mens’) is daarbij...